3rd Quarter - Report

AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION for AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

- Letter to CMS on 2025 Payment Policies under the Medicare Physician Fee Schedule - Letter to CMS on Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Advantage; Medicare and Medicaid Provider and Supplier Enrollment Policies; and Basic Health Program - Letter to Congressional Leadership to reform Medicare Access and CHIP Reauthorization Act (MACRA)

LobbyistCovered position, as disclosed
KRISTIN ANN HELLQUIST —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

- Opposed H.R. 1770/S. 2477 - Letter to FDA on Preventing Counterfeit Drugs & Devices (Botox) - Letter to Surgeon General to to renew the Call to Action to Prevent Skin Cancer

LobbyistCovered position, as disclosed
KRISTIN ANN HELLQUIST —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 2477 (118th), H.R. 1770 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.